What does this research mean for the field?

Question

Accepted Answer

In combination therapy for glioblastoma, virus bursting size is the critical determinant of efficacy, and administering oncolytic viruses simultaneously with or prior to CAR T-cells maximizes therapeutic outcomes. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

CAR T-cell and oncolytic virus dynamics and determinants of combination therapy success for glioblastoma

Discussion

Member takes

Overview

Key Points

Cite This Study